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sophila melanogasterAbstract Aldehyde oxidase (AO) and xanthine oxidoreductase (XOR) are molybdo-ﬂavoenzymes
(MFEs) involved in the oxidation of hundreds of many xenobiotic compounds of which are drugs
and environmental pollutants. Mutations in the XOR and molybdenum cofactor sulfurase (MCS)
genes result in a deﬁciency of XOR or dual AO/XOR deﬁciency respectively. At present despite AO
and XOR being classed as detoxiﬁcation enzymes the deﬁnitive experimental proof of this has not
been assessed in any animal thus far. The aim of this project was to evaluate ry and ma-l strains of
Drosophila melanogaster as experimental models for XOR and dual AO/XOR deﬁciencies respec-
tively and to determine if MFEs have a role in the protection against chemicals. In order to test
the role of the enzymes in chemoprotection, MFE substrates were administered to Drosophila in
media and survivorship was monitored. It was demonstrated that several methylated xanthines were
toxic to XOR-deﬁcient strains. In addition a range of AO substrates including N-heterocyclic pol-
lutants and drugs were signiﬁcantly more toxic to ma-l AO-null strains. This study therefore pro-
vides deﬁnitive proof that both AO and XOR are involved in detoxiﬁcation.
 2016 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Xenobiotics are compounds that are foreign to the body,
which include drugs, pollutants and other substances that are
not normally present in the body that are potentially toxic.
Xenobiotic metabolism is the series of metabolic reactions that
change the chemical structure of xenobiotics; generally acting
to detoxify the toxic chemical compounds. Sometimes, how-
ever, the product of xenobiotic metabolism can be the cause
of toxic effects (Hodgson and Smart, 2001). This study is
concerned with detoxiﬁcation role for two of these enzymesaldehyde oxidase (AO; EC 1.2.3.1) and xanthine oxidoreduc-
tase (XOR; EC 1.2.3.2) against effects of xenobiotics. Those
are molybdo-ﬂavoenzymes (MFEs) found in nearly every
organism from bacteria to human (Garattini et al., 2009;
Garattini and Terao, 2011). Aldehyde oxidase (AO) and xan-
thine oxidoreductase (XOR) are molybdo-ﬂavoenzymes
(MFEs) involved in the oxidation of hundreds of endogenous,
exogenous and N-heterocyclic compounds many of which are
drugs and environmental pollutants (Garattini and Terao,
2011; Hille et al., 2014; Catarina et al., 2015; Dalvie and
Zientek, 2015). Mutations in the XOR and molybdenum
cofactor sulfurase (MCS) genes result in a deﬁciency of XOR
or dual AO/XOR deﬁciency respectively (Amrani et al.,
2000; Ichida et al., 2001). Xanthinuria is an inherited
deﬁciency of XOR, which results in the inability to convert
32 K.S. Al Salhenxanthine and hypoxanthine to uric acid (Holmes and
Wyngaarden, 1989). Hereditary xanthinuria can be subdivided
into two types. Hereditary xanthinuria type I is characterised
by a lack of XOR whereas the type II disease is characterised
by a dual deﬁciency of AO and XOR due to a MCS deﬁciency
genes (Levartovsky et al., 2000; Yamamoto et al., 1991). Dro-
sophila melanogaster have been investigated for a number of
years and ﬁrst mutant that lacked both molybdo-
ﬂavoenzymes were discovered in 1956 (Forrest et al., 1956).
These mutants lack both XOR and AO activity and retain
SO activity (Wahl and Rajagopalan, 1982). Maroon-like locus
(ma-l) homozygotes are completely deﬁcient in XDH and AO
activities (Kamdar et al., 1997) and display a maroon eye col-
our compared to the bright red seen in wild type Drosophila
(Amrani et al., 2000; Wahl and Rajagopalan, 1982). The rosy
gene encodes the XDH apoprotein and rosy mutants show a
normal AO activity (Kidd et al., 1999). The complex and ver-
satile role of XOR, particularly in the mammalian could be
linked to the unique rapid post-translational conversion from
the XDH to the XO form. Only mammalian XOR, but not
XOR from chicken and Drosophila, can be converted from
the XDH to the XO form (Hille and Nishino, 1995; Kooij
et al., 1992). AO and pyridoxal oxidase (PO) enzymes in D.
melanogaster are encoded by aldox and lpo structural loci
(Keller and Glassman, 1964) and were identiﬁed in many adult
Drosophila tissues (Cypher et al., 1982) using heptaldehyde and
2,4,5-trimethoxybenzaldehyde as speciﬁc substrates for AO
and PO, respectively (Cypher et al., 1982). As well as in addi-
tion to studies in Drosophila, AO has been found in antennae
of tobacco hawk moth (Manduca sexta), cabbage armyworm
(Mamestra brassicae), polyphemus silkmoth (Antheraea
polyphemus) and domestic silkworm (Bombyx mori)
(Maibeche-Coisne et al., 2004; Merlin et al., 2005;
Rybczynski et al., 1989, 1990). In addition to enzyme activities
XOR and AO genes have been investigated in several insects.
D. melanogaster has one XDH and four AO (AOX 1–4) genes
were identiﬁed on chromosome 3 (Garattini et al., 2003;
Marelja et al., 2014). The evolution of the AOX genes was
determined and phylogenetic analysis showed that the AOX
gene cluster evolved via independent duplication events in
the vertebrate and invertebrate lineages (Marelja et al.,
2014). Recently, Marelja et al., 2014 have reported that pyri-
doxal oxidase is the product of the Drosophila AOX1 gene.
Uric acid has been shown to be an effective in vitro scavenger
of singlet oxygen, peroxyl radical and hydroxyl radical (Chow,
1988). As ry and ma-l strains cannot produce uric acid as they
are deﬁcient in XDH activity these strains provide a means for
critical in vivo analysis of the role of uric acid in oxygen
defence (Phillips and Hilliker, 1990). Biological models
proposing an important antioxidant role of uric acid predict
that urate-null mutants should be more susceptible to oxygen
radicals. Hilliker et al. (1992) reported an investigation of
the role of uric acid in oxygen defence in ry506 urate-null
mutants. Hilliker et al. (1992) measured the toxic response of
these mutants to oxygen stress imposed by exposure to radical
generating redox cycling agents, ionising radiation, and
increased oxygen tension. The results clearly demonstrated
the in vivo radical-scavenging role of urate and revealed a crit-
ical metabolic role of this classical molybdoenzyme-genetic
system in Drosophila. Hilliker et al. reported that ry506 mutants
are demonstrably impaired in their capacity to detoxify the
active oxygen generated by such diverse agents as paraquat,hyperoxia, and ionising radiation (Hilliker et al., 1992). In
addition, Humphreys et al. found ma-l strain had paraquat
hypersensitivity due to the lack of XDH activity, which leads
to the absence of uric acid (Humphreys et al., 1993). In this
role, uric acid can act either by directly scavenging active oxy-
gen species, in which case it is oxidised into a variety of prod-
ucts including allantoin, oxaluric acid and parabanic acid
(Kaur and Halliwell, 1990) or by binding radical-generating
transition metals into poorly reactive complexes (Davies
et al., 1986). Hamatake et al. also demonstrated that the
urate-null strain was more sensitive to environmental cigarette
smoke (ECS) toxicity than wild type strains (Oregon-R) as
assayed by survival and fecundity. They hypothesised that
oxidative damage seems to be involved in the toxicity of
ECS as uric acid plays a role as an important antioxidant in
Drosophila (Hamatake et al., 2009). It has been proposed that
uric acid has an important role as an antioxidant in vivo and
singlet oxygen scavenger properties and it is important in
determining species longevity (Ames, 1983). AOX is important
in xenobiotic metabolism. Recent focus has been mainly on
in vitro metabolism of pharmaceuticals containing aldehyde
or N-heterocyclic compounds (Kitamura et al., 2006; Pryde
et al., 2010). Recently, results from toxicological research have
shown the toxicological importance role of AOX in vivo in
xenobiotic metabolism in mammals (Swenson et al., 2013).2. Materials and methods
2.1. D. melanogaster strains used for research
D. melanogaster strains were obtained from the Bloomington
Drosophila Stock Centre, Indiana University (USA). All these
strains and mutations were those as described by (Lindsley and
Zimm, 1992).
The following strains were obtained from Bloomington
Drosophila Stock Centre:
Bloomington stock numbers are in parentheses
– Canton-S (1): Normal wild type D. melanogaster (parental
strain).
– ry506 (225): Strain deﬁcient in XOR activity.
– mal-1 (3973) and mal-f1 (180): Strains deﬁcient in MCS
activity.
– Transgenic T1 and T2 strains: ry506 mutant strain trans-
formed with a normal Drosophila XDH gene in Carnegie
20 vector.
2.2. D. melanogaster toxicity tests
All toxicity experiments were carried out at 25 C in a 12 h
light/dark cycle with 3 day old ﬂies being used (Ashburner,
1989). The ﬂies were collected and transferred to the medium
containing different concentrations of the AO and XOR sub-
strates used to evaluate chemoprotection by XOR and AO.
All these substrates were made up in concentrations from
0 mM to 100 mM in distilled water or in appropriate solvents
(Table 1). As the higher concentrations were close to the satu-
ration point of some of the compounds the solutions were
placed in a sonicating bath to increase dissolution of the com-
pound. All the ﬁnal concentrations of these xenobiotics were
Table 1 List of the xenobiotics used in toxicity experiments.
Comments and appropriate solvents are indicated.
Xenobiotics
(stock
concentration)
Comment AO and
XOR
substrate
Solvent
Caﬀeine
(100 mM)
Drug and food
industry
– 10 mM
NaOH
sonicating
Cinchonine
(100 mM)
Anti-malarial drug AO dH2O drops
of 0.1 M
HCl
Paraxanthine
(100 M)
Metabolite of
caﬀeine
XOR 10 mM
NaOH
sonicating
Phenanthridine
(100 mM)
Environmental
pollutant
AO Absolute
ethanol
Pyrazinamide
(100 mM)
Tuberculosis drug AO/XOR 10 mM
NaOH
sonicating
Theobromine
(100 mM)
The primary
methylxanthine in
chocolate
XOR 10 mM
NaOH
sonicating
Theophylline
(100 mM)
Asthma drug XOR 10 mM
NaOH
sonicating
Chemoprotective role of molybdo-ﬂavoenzymes 33prepared by diluting with water before adding the dry ingredi-
ents for the normal culture medium. Care was taken to ensure
uniform distribution of the chemicals by vigorously shaking in
the culture medium. Vials with media were then left to dry for
2 days before use. For the experiments the vials were incubated
at 25 C and the number of survivors recorded every 24 h.
Twenty ﬂies were added to each vial and the survivors were
transferred to new vials containing the same concentration of
xenobiotics every four days (Ashburner, 1989). Control
experiments were carried out using appropriate solvents as
controls.
2.2.1. Survival rate
Survival rates were calculated for all strains by comparing
results from control and xenobiotic supplemented medium
for each strain.
Survival rate ¼ Number of survivors in xenobiotics supplemented medium
Number of survivors in control medium
 1002.3. Statistical analysis
2.3.1. Chi2 Statistical Tests
Using a Chi2 statistical test (v2), it was determined whether or
not the frequency distribution of the collected data was as a
result of something occurring by chance, using the formula:
v2 =
P
(Observed value  Expected value)2/Expected value.
The expected value was calculated as follows:E= (Total of
column  Total of row)/Overall total.The degree of freedom
(df) was calculated as follows:df= (Number of rows  1) 
(Number of columns  1).For these results, the critical values
(5% signiﬁcance or P< 0.05) for v2 were 3.84, 5.99, and 7.82,
since there were 1, 2, and 3 degrees of freedom respectively.3. Results
3.1. Investigation of the chemoprotective role of molybdo-
flavoenzymes against xenobiotic toxicity
The study of the chemoprotective role of MFEs was performed
by adding a variety of known AO and XOR substrates to the
Drosophila media. Percentage survival was assessed over a one
to ﬁve week time course depending on the compounds being
scrutinised.
3.1.1. Investigation of the chemoprotective role of molybdo-
flavoenzymes with purine and purine based drugs in D.
melanogaster strains
Following the analysis of endogenous purines Drosophila were
kept on either 20 mM or 100 mM caffeine (1,3,7-
trimethylxanthine), theophylline (1,3-dimethylxanthine),
paraxanthine (1,7-dimethylxanthine) and theobromine (3,7-
dimethylxanthine) for up to 2 weeks. The results of the toxicity
study are presented in Fig. 1. All methylxanthines with the
exception of paraxanthine tested were signiﬁcantly more toxic
to XOR-deﬁcient rosy and ma-l strains than wild type
(Canton-S) or transgenic (T1 and T2) strains at 20 mM. As
there was no toxic effect at 20 mM paraxanthine with any
strain (data not shown) a 100 mM dose was used that showed
a similar pattern of toxicity to the strains tested with XOR-
deﬁcient strains having a much more pronounced death rate.
3.1.2. Investigation of the chemoprotective role of molybdo-
flavoenzymes with toxicity of non-purine based N-heterocyclic
compounds in D. melanogaster strains
Several other non-purine based N-heterocyclic compounds
were used in the toxicity studies. These included phenan-
thridine (an AO substrate and environmental pollutant),
pyrazinamide (an AO and XOR substrate and anti-
tuberculosis drug) and cinchonine (an AO substrate and
anti-malarial). When these compounds were administered in
ﬂy media as described in method and materials the following
graphs were obtained (Fig. 2). This illustrates the percentage
survival of Drosophila strains after treating with 20 mM con-
centration of these compounds in media. The maroon-like
strains appeared weaker as they had a higher mortality rate
than that of the rosy, transgenic and wild type strains with
all compounds. With phenanthridine and cinchonine there
was no signiﬁcant difference between ry506, transgenic and wild
type strains (Fig. 2). In contrast, pyrazinamide caused a faster
death rate and highly signiﬁcant difference (Table 2)
(P< 0.05) when the ry506 strain was compared to the two
MFE-active strains and there was a slightly signiﬁcant differ-
ence than ma-l strains (Fig. 2).
4. Discussion
4.1. The chemoprotective role of molybdo-flavoenzymes against
xenobiotic toxicity
At present despite MFEs being classed as phase I detoxication
enzymes (Hodgson and Smart, 2001; Pryde et al., 2010) their
role in chemoprotection in vivo has not been proven. It is an
objective of this section to measure the physiological
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Figure 1 Toxicity of methyl-xanthines to Drosophila melanogaster strains (a) caffeine (20 mM), (b) theobromine (20 mM), (c)
theophylline (20 mM) and (d) paraxanthine (100 mM). Each vial contained twenty, 0–3 days old male ﬂies, each point represents mean
± SD of four sets of data. CS = Canton-S. T1 and T2 = transgenic.
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Figure 2 Toxicity of 20 mM phenanthridine, pyrazinamide and
cinchonine to wild type, transgenic and mutant of Drosophila
melanogaster strains. (a) phenanthridine, (b) pyrazinamide and (c)
cinchonine. Each vial contained twenty, 0–3 days old male ﬂies,
each point represents mean ± SD of four sets of data. CS = Can-
ton-S. T1 and T2 = transgenic.
34 K.S. Al Salhendetoxiﬁcation role of AO and XDH in D. melanogaster strains
(wild type, transgenic and mutants). The potential toxicants
used to evaluate this included drug such as cinchonine(anti-malaria drug) and pyrazinamide (tuberculosis drug).
Another well-known AO substrate is phenanthridine (environ-
mental pollutant). Methylxanthines (caffeine, theobromine,
theophylline and paraxanthine) were also used to test the
detoxiﬁcative role of XDH.
4.1.1. In vivo metabolism and toxicity of methylxanthines on D.
melanogaster strains
It can be seen in Fig. 1 that when the strains are exposed to
20 mM of caffeine, theophylline and theobromine there was
a difference in the survival times of different strains. Mutant
strains (ry506, mal-1 and mal-f1) had a higher sensitivity to
the toxic methylxanthines than wild type (Canton-S) and
transgenically rescued (T1 and T2) strains. Because all of the
Drosophila strains were not affected by a dose of 20 mM
paraxanthine, a higher dose of 100 mM was given to observe
effects for mutant strains (Fig. 1). There was no difference
between the Canton-S and the transgenic T2 and T1 strains
of Drosophila which suggests that the transgenic ry strains
had been rescued by the insertion of ry gene. This also demon-
strated that it was the XDH gene that was conferring protec-
tion as mutant ry506 had a much reduced survival time. All
toxicity results show that the mutant strains (ry506, mal-1
and mal-f1) have a higher sensitivity to the toxic methylxanthi-
nes than wild type (Canton-S) and transgenically rescued (T1
and T2) strains. The lifespan of mutant (ry506 and maroon-
like) strains were reduced to 9 days when exposed to
100 mM of paraxanthine, but wild type and transgenic rescued
strains were unaffected by this treatment. With regard to the
biochemical basis of the results obtained, caffeine and theo-
phylline, theobromine and paraxanthine ingested are partly
broken down into its metabolites by the cytochrome
P4501A2 (CYP1A2), N-acetyltransferase and XDH
enzymes (Rasmussen and Brosen, 1996). So, without XDH,
the maroon-like and ry506 strains cannot fully catabolise the
caffeine metabolites as the missing enzyme converts the
Table 2 Statistical differences in survival between wild type, transgenic and mutant strains after exposure to xenobiotics.
Xenobiotics and v2 value Strain
Canton-S ry506
T1 T2 ry506 mal-1 mal-f1 mal-1 mal-f1
Caﬀeine (20 mM) v2= 0.02 0.01 18.42* 26.66* 12.84* 26.66* 12.84*
Cinchonine (20 mM) v2= 0.07 0.08 0.02 8.28* 9.85* 7.21* 8.01*
Paraxanthine (100 mM) v2= 0.004 0.02 18.65* 17.94* 20.97* 17.94* 20.97*
Phenanthridine (20 mM) v2= 0.002 0.0002 0.001 49.29* 50.28* 48.72* 47.12*
Pyrazinamide (20 mM) v2= 0.0001 0.0006 27.236* 36.83* 37.69* 5.83* 5.51*
Theobromine (20 mM) v2= 0.001 0.002 24.24* 24.38* 24.55* 24.38* 24.55*
Theophylline (20 mM) v2= 0.01 0.01 9.92* 13.69* 12.67* 13.69* 12.67*
(*P< 0.05 by chi2 test is 3.84) indicates when a value is signiﬁcantly different from the control value.
Chemoprotective role of molybdo-ﬂavoenzymes 35methyl-xanthines to the more polar methyl-uric acids in the
ﬁnal steps of caffeine degradation. The mutant strains were
affected more by the absence of the XDH, but the wild type
and transgenic strains are still affected by the 20 mM caffeine
and theophylline and all ﬂies were dead after 13 days. By com-
paring the toxicity of methylxanthines treated with wild type
and transgenic Drosophila strains it was found that caffeine
(20 mM; Fig. 1) has a greater toxicity than theophylline
(20 mM; Fig. 1). This agrees with the result of Zimmering
et al., 1977 that found that caffeine is lethal to adult D. mela-
nogaster (Zimmering et al., 1977) and at a lower concentration
decreases longevity and fecundity in Drosophila prosaltans
(Carrillo and Gibson, 2002). Graf and Wurgler (1986) found
that caffeine media with 4% w/v killed approximately 75%
of exposed ﬂies. Zimmering et al. (1977) found a high mortality
rate in the ry506 ﬂies after three days of exposure to 1.25–
2.5 mg/ml caffeine. Zimmering et al. (1977) found that the
Canton-S strains mortality rate was around 40% after three
days, which is higher than the results obtained from the cur-
rent toxicity test (40% after 8 days). From the ry506 strain used
in the Zimmering et al. (1977) study the mortality rate was
almost 100% after three days, which is slightly higher than this
current toxicity test found (100% dead after 6 days). This
result conﬁrms the fact that caffeine is not only mutagenic
but it also causes a reduction in lifespan (Kuhlmann et al.,
1968). Nikitin et al. (2008) showed that the lifespan of
Canton-S D. melanogaster males is reduced at varying caffeine
concentrations (1.5–13 mM) (Nikitin et al., 2008). However,
theobromine (20 mM) is much less active than caffeine or theo-
phylline (Tarka, 1982), with regard to the above results
(Fig. 1). Similarly paraxanthine showed a weak toxicity and
wild type and transgenic strains were only affected by a higher
dose of paraxanthine (100 mM; Fig. 1). Cozk 1974 reported
the action of the theobromine in the central nervous system
is weak or virtually absent (Czok, 1974), which agrees with
the results obtained from the current toxicity test (20 mM
theobromine had no effect in Canton-S and transgenic strains
during experiment). The literature is devoid of any reference to
human toxicity data on theobromine, except one general state-
ment that ‘‘in large doses” theobromine may cause nausea and
anorexia (Pharmacopeia, 1984). Comparative results for the
acute toxicity of caffeine, theophylline and theobromine given
orally for mouse and rat, it is of interest to note a very similar
acute toxicity for caffeine and theophylline in the rat whereastheobromine appeared to have no toxicity (Stravic, 1988;
Tarka, 1982). These results agree with the results obtained
from the current toxicity study. Paraxanthine, although not
found in plants or foods, is a major metabolite of caffeine in
humans (Aranda et al., 1983). There is little information in
the literature concerning its toxicological potential, but the
available information indicates that its toxicological potency
in man is very low (Stravic, 1988). In spite of this, there is sur-
prisingly little information in the literature about the toxico-
logical potential of paraxanthine, especially in humans. A
number of major reference books, including the Merck Index
(10th ed.) and Martindale-The Extra Pharmacopoeia (1982),
do not list paraxanthine (Stravic, 1988). These results agree
with the paraxanthine results obtained from the current toxic-
ity study in that 100 mM paraxanthine did not have an effect
on the Canton-S and transgenic strains (shown Fig. 1). In con-
clusion, it may be the speciﬁc locations of methyl groups on
the purine ring are important determinants on the biological
effects of these compounds. Because theobromine (3,7-
dimethylxanthine) and paraxanthine (1,7-dimethylxanthine)
were not toxic to Canton-S and transgenic strains, but caffeine
(1,3,7 trimethyl-xanthine) and theophylline (1,3-
dimethylxanthine) were toxic, these ﬁndings may be compara-
ble to the results of Ho et al. who reported that several purines
such as purine, adenine, 2,6 purine, xanthine and guanine have
different effects on the survival rate of D. melanogaster related
to the speciﬁc location of amino and carboxyl groups, because
these positions on the purine ring were important determinants
of the biological effects of these compounds (Ho et al., 1984).
In the study detailed in this thesis it was concluded that the
methyl groups in the number 1 and 3 positions (theophylline)
were more critical than the number 3 and 7 positions (theo-
bromine), whilst the number 1 and 7 positions (paraxanthine)
were not toxic to the wild type (Canton-S) strain. The three
positions of methyl groups in purine ring of caffeine (1,3,7-
trimethylxanthine) were critical to survival of Canton-S strain.
Overall the results of the studies here show that the loss of AO
and/or XOR activity combined (ma-l strains) had greater effect
on the ability of Drosophila to survive in the methylxanthine
media than the deﬁciency of XOR alone (ry506 strain). This
suggests that AO has either an involvement in the metabolism
of methylxanthines or secondary protective effect. This drug
was also investigated to discover any toxic effects in the
different Drosophila strains. The results of ﬂies fed on media
Table 3 Summary of the toxicity of purines based and N-heterocycles compounds to Drosophila
melanogaster strains.
None: not affected  
Yellow: 2-7days, blue: 8-15 days and green: None. 
Compound 
50% mortality (days) 100% mortality (days) 
Canton-S ry506 mal-f1 Canton-S ry506 mal-1 mal-f1 
Caffeine (20mM) 9 3 2 2 13 8 6 6 
Cinchonine (20mM) 4  3 2 2 8 8 5 5 
Paraxanthine (100mM) None 4  4  4  None 9 9  9  
Phenanthridine (20m) None None 6  6  None None 12  13  
Pyrazinamide (20 mM) None 5  5  5  None 12  8 8 
Theobromine (20mM) None 3 3 3 None 8 8 8 
Theophylline (20mM) 8 4  4  4  13 10 7 8 
mal-1 
36 K.S. Al Salhencontaining 20 mM pyrazinamide are shown in Fig. 2. In terms
of Canton-S and transgenic strains there was no effect by
pyrazinamide, but mutant strains (ry506, mal-1 and mal-f1)
were affected by pyrazinamide toxicity and the mortality starts
from the early days of exposure, probably due to the absence
of XOR or AO/XOR enzymes and lack of any oxidation prod-
ucts in vitro studies. The difference observed between the
mutant strains, transgenic and wild type strains supports the
conclusion that lack of MFEs is responsible for the strains
reduced survival in the presence of toxin. The caffeine,
theobromine and theophylline had similar effects, as these
compounds were not biotransformed by Drosophila
molybdo-ﬂavoenzymes. In contrast, the phenanthridine and
pyrazinamide, which are substrates for AO and/or XOR,
had no or less toxic effect on the wild type and transgenic
strains due to these substrates being in vivo biotransformed
by AO and/or XOR in Drosophila. A summary of the relative
toxicity of each compound is shown in Table 3.
As seen in Table 3 it was observed that of the compounds
tested the anti-malarial alkaloid cinchonine was the most
toxic of the compounds tested, killing wild type and ry506
ﬂies within 7 days and maroon-like strains within 5 days of
administration of a 20 mM concentration in media. This
may be due to the fact that it has more efﬁcient properties
in increasing the intracellular cytotoxicity (Genne et al.,
1994). The second most potent class was alkylated purine
drugs, caffeine and theophylline with wild type strain dying
within 13 days of administration. It was determined that
the maximum life of mutant (ry506 and ma-l) ﬂies was 8 days
of administration of a 20 mM concentration of caffeine and
theophylline in media (Table 3). Theobromine was more
toxic with ry506 and maroon-like strains dying within 8 days,
but it had no lethality at 20 mM concentration with wild
type strain. Paraxanthine had no lethality at low and higher
doses of 20 and 100 mM respectively with wild type
strain. The urban air pollutant phenanthridine had no toxic-
ity at any dose tested for wild type and ry506 strains. The
anti-tuberculosis drug, pyrazinamide had no toxicity at
20 mM tested for wild type strain. In comparison, a great
toxicity effect was observed on the lifespan of the maroon-
like strains (mal-1 and mal-f1) when exposed to the toxicity
of purines and N-heterocyclic compounds (Table 3) that
are AO substrates indicating its essential role in chemopro-
tection in vivo.5. Conclusions
Prior to this study despite AO and XOR being classed as
detoxiﬁcation enzymes there is no published unequivocal proof
of this. In this study two mutant strains of D. melanogaster
were used as animal models to investigate this. Rosy (ry)
strains have a deﬁciency in XOR, whilst maroon-like (ma-l)
have a lack of functional AO/XOR due to a MCS deﬁciency.
In order to test the role of the enzymes in chemoprotection
MFE substrates were administered in Drosophila media and
survivorship was monitored. This demonstrated that several
methylated xanthines including caffeine, theophylline, parax-
anthine and theobromine were toxic to XOR-deﬁcient strains.
In addition a range of AO substrates including N-heterocyclic
pollutants and drugs were toxic to ma-l AO-null strains. This
study therefore provides unequivocal proof that both AO
and XOR are involved in detoxiﬁcation.
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